Impact of proton pump inhibitors and antibiotics on efficacy of nivolumab in patients with R/M HNSCC

被引:0
|
作者
Wada, Akihisa [1 ]
Enokida, Tomohiro [1 ]
Okano, Susumu [1 ]
Sato, Masanobu [1 ]
Tanaka, Hideki [1 ]
Ueda, Yuri [1 ]
Fujisawa, Takao [1 ]
Takeshita, Naohiro [1 ]
Tanaka, Nobukazu [1 ]
Tahara, Makoto [1 ]
机构
[1] Natl Canc Ctr Hosp East, Dept Head & Neck Med Oncol, Kashiwa, Chiba, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
O2-5
引用
收藏
页码:S469 / S469
页数:1
相关论文
共 50 条
  • [1] Proton pump inhibitors and antibiotics adversely effect the efficacy of nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Wada, Akihisa
    Enokida, Tomohiro
    Okano, Susumu
    Sato, Masanobu
    Tanaka, Hideki
    Ueda, Yuri
    Fujisawa, Takao
    Takeshita, Naohiro
    Tanaka, Nobukazu
    Tahara, Makoto
    EUROPEAN JOURNAL OF CANCER, 2023, 184 : 30 - 38
  • [2] Impact of Antibiotics and Proton Pump Inhibitors on Efficacy and Tolerance of Anti-PD-1 Immune Checkpoint Inhibitors
    Giordan, Quentin
    Salleron, Julia
    Vallance, Catherine
    Moriana, Clothilde
    Clement-Duchene, Christelle
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [3] What Is the Real Impact of Concomitant Antibiotics or Proton Pump Inhibitors on Efficacy of Atezolizumab-Based Regimens in Patients With NSCLC?
    Mazzaschi, Giulia
    Buti, Sebastiano
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (10) : E89 - E90
  • [4] The effect of proton pump inhibitors on the efficacy of nivolumab monotherapy in different types of cancer
    Quy Pham Nguyen
    Nomura, Motoo
    Matsumoto, Shigemi
    Muto, Manabu
    ANNALS OF ONCOLOGY, 2019, 30 : 115 - 115
  • [5] What Is the Real Impact of Concomitant Antibiotics or Proton Pump Inhibitors on Efficacy of Atezolizumab-Based Regimens in Patients With NSCLC? Response
    Hopkins, Ashley M.
    Sorich, Michael J.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (10) : E90 - E90
  • [6] Impact of proton pump inhibitors on efficacy of clopidogrel: Review of evidence
    Mistry, Suresh D.
    Trivedi, Hiren R.
    Parmar, Dinesh M.
    Dalvi, Prashant S.
    Jiyo, Chacko
    INDIAN JOURNAL OF PHARMACOLOGY, 2011, 43 (02) : 183 - 186
  • [7] Proton pump inhibitors and antibiotics impact on toxicities and clinical outcomes in cancer patients treated with immunotherapy.
    Araujo, Haniel Alves
    Venchiarutti Moniz, Camila Motta
    Melro Braghiroli, Oddone Freitas
    Mak, Milena Perez
    Uratani, Lucas Fernando
    Tiecher, Ricardo Dahmer
    Moraes, Priscila Muniz
    Barbosa, Ingrid
    De Camargo, Veridiana Pires
    Freitas Melro Braghiroli, Maria Ignez
    Castro, Gilberto
    Hoff, Paulo Marcelo
    Diz, Maria Del Pilar
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] Proton pump inhibitors decrease efficacy of palbociclib in patients with metastatic breast
    Criado, Javier alvarez
    Aunon, Pilar Zamora
    Marin, Virginia Martinez
    Cabetas, Macarena GarciaTrevijano
    Sanchez, Victoria Lucia Collada
    Arranz, Enrique Espinosa
    Romero-Garrido, Jose Antonio
    Benedi-Gonzalez, Juana
    Almiron, Mariana Diaz
    Ambrosio, Alicia Herrero
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024,
  • [9] Impact of sarcopenia (S) on efficacy and toxicity of nivolumab (N) in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) in TOPNIVO (T) study
    Muratori, L.
    Texier, M.
    Mayache-Badis, L.
    Bidault, F.
    Iacob, M.
    Daste, A.
    Fayette, J.
    Lefebvre, G.
    Saada-Bouzid, E.
    Zanetta, S.
    Toullec, C.
    Cupissol, D.
    Salas, S.
    Kaminsky-Forrett, M-C.
    Johnson, A. C.
    Ferrand, F. R.
    Auperin, A.
    Guigay, J.
    Raynard, B.
    Even, C.
    ANNALS OF ONCOLOGY, 2021, 32 : S809 - S810
  • [10] Proton pump inhibitors: An assessment of efficacy and safety
    Chen, BP
    Chow, MSS
    FORMULARY, 1999, 34 (05) : 437 - +